China Biopharma , könnte in ein paar Jahren 1000 % + x bringen.........lesen............ - 500 Beiträge pro Seite

[GoldenStock]

Denke man sollte mal einen Fuß in die Tür stellen, und einfach mal 2-3 Jahre liegen lassen.
Könnte durchaus sein, das man aus 1000 € Einsatz , plötzlich (2-3 Jahre) 50.000 Euro auf dem Konto stehen hat.(m.M.)
GoldenStock
-----------------------------------------------------------

China Biopharma Reaches Agreement to Introduce a New Antiviral Drug
PR Newswire
June 21, 2007: 08:00 AM EST

PRINCETON, N.J., June 21 /PRNewswire-FirstCall/ -- China Biopharma, Inc. announced that it has reached agreements with Soonfast Pharmaceutical Science & Technology Co., Ltd. ("Soonfast") to introduce a new antiviral medicine into the overseas market including the United States and European countries. This all-natural medicine has been approved in China for external use to treat human papillomavirus ("HPV") and herpes simplex virus ("HSV"). Tests have shown an inhibitory effect on the growth of HPV and HSV, and the medicine can reduce the infection from HPV and HSV by 90% only in 2-3 days. Experiments have also proved that the herbal can kill all of the HPV types 6/11/16/18 and 33.

Human papillomavirus infection is common across all races and socioeconomic groups and is prevalent throughout the world in sexually active persons. HPVs are the most common sexually transmitted viral agents in the United States, infecting up to 20% people aged 15 to 49. In the last 30 years, the incidence of HPV infection has increased dramatically. Despite the prevalence of HPV, no available drug therapy effectively eliminates HPV infection and replication or prevents HPV-associated malignant progression. Consequently, there is an urgent medical need unmet for the development of safe and effective therapies for HPV-associated diseases. According to a research by Decision Resources, the market for HPV treatment is expected to grow from $135 million in 2002 to $1.4 billion (€1.08 billion) in 2012.

China Biopharma will utilize its presence in both US and China to initially introduce this all-natural external-use medicine. The company and Soonfast also plan to jointly conduct studies on its extracts in both China and USA so as to obtain approval necessary for selling this medicine as an over-the-counter drug. The company believes this medicine would bring in significant revenue and profit in the near future once it is successfully introduced into the market.

About China Biopharma, Inc.

China Biopharma Inc. is a fast-growing biopharmaceutical company based in China. Through its operating subsidiaries, the company develops and distributes biopharmaceutical and pharmaceutical products throughout the world's most populated country, China. Products include human vaccines and other pharmaceutical drugs. Leveraging its investment and ownership of local Chinese biopharmaceutical companies, and partnerships with international biopharmaceutical companies, China Biopharma is building a highly-competitive platform for growth in China as well as new world markets, including the U.S. and Europe. For more information, visit its website at http://www.chinabiopharma.net.

CONTACT:

China Biopharma, Inc.
Attn.: George Ji
Tel: [phone]
[e-mail]
http://www.chinabiopharma.net

Safe Harbor Statement

Some of the statements here discuss future events and developments, including the Company's future business strategy and its ability to generate revenue, income and cash flow, and should be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These "forward-looking" statements can generally be identified by words such as "expect," "anticipate," "believe," "estimate," "intend," "plan," and similar expressions. These statements involve a high degree of risk and uncertainty that exists in the Company's operations and business environment and are subject to change based on various factors that could cause actual Company results, performance, plans, goals and objectives to differ materially from those contemplated or implied in these forward-looking statements. Actual results may be different from anticipated results for a number of reasons, including the Company's new and uncertain business model, uncertainty regarding acceptance of the Company's products and services and the Company's limited operating history.

China Biopharma, Inc.

[@all4me]

Hi

was get da ab???

[GoldenStock]

Denke die positiven Aussichten für 2007 finden
langesam auch im Kurs ihr Bild.


Immerhin erwartet man 2007 Umsätze von über 10 Mio Dollar.

Und man will weiter (weltweit) durch Kooperation AGRESSIV wachsen.

Denke bei einer Marktkap. von derzeit um die 9 Mio Dollar , eröffnet sich ein Potential (falls alles so eintrifft wie geplant) ,
auf Sicht von 1-2 Jahren von durchaus ca. 1000 %.

Denke eine Marktkap. von dann ca. 90 Mio Dollar, wäre dann
nicht zu teuer...., vor allem weil man von Anfang an , PROFITABLE , d.h. Gewinne machen will.........

GoldenStock

[Vzappi]

so ruhig hier, die geht ab wie ne Rakete!!!

BOOOOOOM

[Vzappi]

+ 82,6%
Vol 22,000,000 Stk.

MK: akt. 3,78 Mio
assets: 7,000,000 USD
Aktien: ca. 90 Mio Stk. (14.05.07)


Ist denn sonst niemand mit dabei?

[Vzappi]

yeeeeehhhhaaaaa!